INMB   $5.03  -1.57% Market Open

INmune Bio Inc
Total Cash 31.07M
totalCashPerShare 1.571
EBITDA
Total Debt 5.43M
quickRatio 2.291
currentRatio 2.358
Total Revenue 85.00K
debtToEquity 14.647
Revenue/Share 0.005
ROA -0.38662997
ROE -0.86037004
grossProfits
freeCashflow -9.25M
operatingCashflow -23.03M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -444.57648
profitMargins 0.0
enterpriseValue 70.71M
forwardPE -2.5725
floatShares 14.05M
sharesOutstanding 19.83M
sharesShort 2.68M
sharesShortPriorMonth 3.02M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.21%
Short Ratio help_outline 8.29%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue 1.841
Price To Book help_outline 2.79
earningsQuarterlyGrowth
netIncomeToCommon -37.74M
trailingEps -2.05%
forwardEps -2.00%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.51 3Q 2024
institutionsCount 83
lastUpdated Oct. 16, 2024, 8:10 p.m.